Images

Alzheimer’s disease can be characterized by three main phases – preclinical AD, MCI (Mild Cognitive Impairment) and dementia.

This infographic provides a visual, at-a-glance overview of why biomarkers in schizophrenia are relevant for clinicians, what is necessary to bring biomarkers to the clinic and neuroimaging biomarkers in schizophrenia management.

20 million+ individuals globally live with schizophrenia. Schizophrenia is associated with significant impairments in psychosocial function. This infographic provides a visual, at-a-glance overview of the epidemiology, economic cost and the global impact of schizophrenia.

Migraine attacks can be broken down into four phases: prodrome, aura, headache, and postdrome, as shown on the image. The exact timing of each phase is highly variable; the headache phase of a migraine can range from 4–72 hours in adults, and 2–48 hours in children.

In vivo quantification of tau can be performed using tau-PET (PET: positron emission tomography). This illustration represents the stages of tau pathology measured by PET.

Currently, CSF p-tau181, Aβ42/40, and total tau are used to diagnose AD in clinical practice. P-tau217 has recently gained attention due to its high sensitivity and specificity for AD.